TABLE 2.
Clinicopathologic features of the patients
| Variable | Data |
|---|---|
| Age (mean ± SD) (years) | 54.00 ± 7.91 |
| Maximum diameter (mean ± SD) (mm) | 25.10 (13.76, 42.58) |
| FIGO stage n (%) | |
| IA | 44 (59.46) |
| IB | 30 (40.54) |
| Histologic subtype n (%) | |
| Adenocarcinoma | 67 (90.54) |
| Non-adenocarcinoma | 7 (9.46) |
| Clear-cell | 3 (4.06) |
| Undifferentiated carcinoma | 2 (2.70) |
| Carcinosarcoma | 2 (2.70) |
| Lymphovascular space invasion n (%) | |
| Positive | 10 (6.76) |
| Negative | 64 (93.24) |
| Histologic grade n (%) | |
| Grade 1 | 54 (72.98) |
| Grade 2 | 10 (13.51) |
| Grade 3 | 10 (13.51) |
| Risk stratification n (%) | |
| Low | 44 (59.46) |
| Intermediate | 20 (27.03) |
| High-intermediate | 0 (0.00) |
| High | 10 (13.51) |
| TP53 expression | |
| Mutant | 21 (28.38) |
| Wild | 25 (33.78) |
| No result | 28 (37.84) |
FIGO = International Federation of Gynecology and Obstetrics; SD = standard deviation